1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of Fluorescein Angiography Market By Product, By Technology, By Application, By End User, And By Region (Global Market Forecast To 2027)

Global Market Analysis Of Fluorescein Angiography Market By Product, By Technology, By Application, By End User, And By Region (Global Market Forecast To 2027)

Publication Month: Jun 2020 | No. of Pages: 126 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global Fluorescein Angiography market is estimated at $ 494.5 million in 2019, and expected to reach $ 616.75 million by 2027, with a CAGR of 2.8% from 2020 to 2027.

Fluorescein angiography is a medical procedure in which an ophthalmologist will inject a fluorescent dye into the bloodstream this further highlight the blood vessels in the back of the eye so that it will help ophthalmologist to get a better look at the blood vessels and other structures in the back of the eye.   

Market Dynamics

The Global Fluorescein Angiography market is primarily driven by factors such as the growing occurrences of eye diseases such as diabetes retinopathy, macular degeneration, etc.; growing demand for early disease diagnosis; growing government initiatives; growing awareness; growing geriatric population; technological innovation; favorable reimbursement policies; are some of the market dynamics.

Market Segmentation

The Global Fluorescein Angiography Market is mainly classified based on Product, Technology, Application, End User, and Region.

  • Based on Product, the market is further segmented into  Devices, Disposables (Dye and Film), and Accessories
  • Based on Technology, the market is further segmented into Analog and Digital
  • Based on Application, the market is further segmented into Diabetes Retinopathy, Macular Edema, Macular Pucker, Macular Degeneration, Ocular Melanoma, and Others  
  • Based on End User, the market is further segmented into Hospitals, Specialty Clinic, Other Users

Regional Analysis

Based on geography, the Global Fluorescein Angiography market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa                                                                                                

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape                     

Global Fluorescein Angiography Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global Fluorescein Angiography sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2019-2027, this study provides the Global Fluorescein Angiography sales, revenue and market share for each player covered in this report.           

The major players covered in Global Fluorescein Angiography are CenterVue SpA, Carl Zeiss Meditec Inc., Optomed Oy Ltd., Kowa Company Ltd., Canon Inc., Nidek Co. Ltd., Clarity Medical Systems Inc., Topcon Medical Systems Inc., and other prominent players.

Fluorescein Angiography Market Key Segments:

By Product

  • Devices
  • Disposables         
    • Dye
    • Film
  • Accessories

By Technology   

  • Analog
  • Digital

By Application   

  • Diabetes Retinopathy
  • Macular Edema
  • Macular Pucker
  • Macular Degeneration
  • Ocular Melanoma
  • Others 

By End User

  • Hospitals
  • Specialty Clinics
  • Other Users

By Region             

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1 Market Overview

1.1 Fluorescein Angiography Introduction

1.2 Market Analysis by Product

1.2.1 Overview: Global Fluorescein Angiography Revenue by Product: 2019 VS 2021 VS 2027

1.2.2 Devices

1.2.3 Disposable

1.2.3.1 Dye

1.2.3.2 Film

1.2.4 Accessories

1.3 Market Analysis by Technology

1.3.1 Overview: Global Fluorescein Angiography Revenue by Technology: 2019 VS 2021 VS 2027

1.3.2 Analog

1.3.3 Digital

1.4 Market Analysis by Application

1.4.1 Overview: Global Fluorescein Angiography Revenue by Application: 2019 VS 2021 VS 2027

1.4.2 Diabetes Retinopathy

1.4.3 Macular Edema

1.4.4 Macular Pucker

1.4.5 Macular Degeneration

1.4.6 Ocular Melanoma

1.4.7 Other Applications

1.5 Market Analysis by End User

1.5.1 Overview: Global Fluorescein Angiography Revenue by End User: 2019 VS 2021 VS 2027

1.5.2 Hospitals

1.5.3 Specialty Clinics

1.5.4 Other Users

1.6 Overview of Global Fluorescein Angiography Market

1.6.1 Global Fluorescein Angiography Market Status and Outlook (2019-2027)

1.6.2 North America (United States, Canada and Mexico)

1.6.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.6.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.6.5 South America, Middle East & Africa

1.7 Market Dynamics

1.7.1 Market Opportunities

1.7.2 Market Risk

1.7.3 Market Driving Force

2 Manufacturers Profiles

2.1 CenterVue SpA

2.1.1 CenterVue SpA Details

2.1.2 CenterVue SpA Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 CenterVue SpA SWOT Analysis

2.1.4 CenterVue SpA Product and Services

2.1.5 CenterVue SpA Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.2 Carl Zeiss Meditec Inc.

2.2.1 Carl Zeiss Meditec Inc. Details

2.2.2 Carl Zeiss Meditec Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Carl Zeiss Meditec Inc. SWOT Analysis

2.2.4 Carl Zeiss Meditec Inc. Product and Services

2.2.5 Carl Zeiss Meditec Inc. Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.3 Optomed Oy Ltd.

2.3.1 Optomed Oy Ltd. Details

2.3.2 Optomed Oy Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Optomed Oy Ltd. SWOT Analysis

2.3.4 Optomed Oy Ltd. Product and Services

2.3.5 Optomed Oy Ltd. Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.4 Kowa Company Ltd.

2.4.1 Kowa Company Ltd. Details

2.4.2 Kowa Company Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Kowa Company Ltd. SWOT Analysis

2.4.4 Kowa Company Ltd. Product and Services

2.4.5 Kowa Company Ltd. Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.5 Canon Inc.

2.5.1 Canon Inc. Details

2.5.2 Canon Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Canon Inc. SWOT Analysis

2.5.4 Canon Inc. on Product and Services

2.5.5 Canon Inc. Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.6 Nidek Co. Ltd.

2.6.1 Nidek Co. Ltd. Details

2.6.2 Nidek Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Nidek Co. Ltd. SWOT Analysis

2.6.4 Nidek Co. Ltd. Product and Services

2.6.5 Nidek Co. Ltd. Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.7 Clarity Medical Systems Inc.

2.7.1 Clarity Medical Systems Inc. Details

2.7.2 Clarity Medical Systems Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Clarity Medical Systems Inc. SWOT Analysis

2.7.4 Clarity Medical Systems Inc. Product and Services

2.7.5 Clarity Medical Systems Inc. Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.8 Topcon Medical Systems Inc.

2.8.1 Topcon Medical Systems Inc. Details

2.8.2 Topcon Medical Systems Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Topcon Medical Systems Inc. SWOT Analysis

2.8.4 Topcon Medical Systems Inc. Product and Services

2.8.5 Topcon Medical Systems Inc. Fluorescein Angiography Sales, Price, Revenue, Gross Margin and Market Share (2019-2020)

2.9 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Fluorescein Angiography Sales and Market Share by Manufacturer (2019-2020)

3.2 Global Fluorescein Angiography Revenue and Market Share by Manufacturer (2019-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 Fluorescein Angiography Manufacturer Market Share in 2019 & 2020

3.3.2 Top 6 Fluorescein Angiography Manufacturer Market Share in 2019 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Fluorescein Angiography Sales, Revenue and Market Share by Regions

4.1.1 Global Fluorescein Angiography Sales and Market Share by Regions (2019-2020)

4.1.2 Global Fluorescein Angiography Revenue and Market Share by Regions (2019-2020)

4.2 North America Fluorescein Angiography Sales and Growth Rate (2019-2020)

4.3 Europe Fluorescein Angiography Sales and Growth Rate (2019-2020)

4.4 Asia-Pacific Fluorescein Angiography Sales and Growth Rate (2019-2020)

4.5 South America Fluorescein Angiography Sales and Growth Rate (2019-2020)

4.6 Middle East and Africa Fluorescein Angiography Sales and Growth Rate (2019-2020)

5 North America by Country

5.1 North America Fluorescein Angiography Sales, Revenue and Market Share by Country

5.1.1 North America Fluorescein Angiography Sales and Market Share by Country (2019-2020)

5.1.2 North America Fluorescein Angiography Revenue and Market Share by Country (2019-2020)

5.2 United States Fluorescein Angiography Sales and Growth Rate (2019-2020)

5.3 Canada Fluorescein Angiography Sales and Growth Rate (2019-2020)

5.4 Mexico Fluorescein Angiography Sales and Growth Rate (2019-2020)

6 Europe by Country

6.1 Europe Fluorescein Angiography Sales, Revenue and Market Share by Country

6.1.1 Europe Fluorescein Angiography Sales and Market Share by Country (2019-2020)

6.1.2 Europe Fluorescein Angiography Revenue and Market Share by Country (2019-2020)

6.2 Germany Fluorescein Angiography Sales and Growth Rate (2019-2020)

6.3 UK Fluorescein Angiography Sales and Growth Rate (2019-2020)

6.4 France Fluorescein Angiography Sales and Growth Rate (2019-2020)

6.5 Russia Fluorescein Angiography Sales and Growth Rate (2019-2020)

6.6 Italy Fluorescein Angiography Sales and Growth Rate (2019-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Fluorescein Angiography Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Fluorescein Angiography Sales and Market Share by Regions (2019-2020)

7.1.2 Asia-Pacific Fluorescein Angiography Revenue and Market Share by Regions (2019-2020)

7.2 China Fluorescein Angiography Sales and Growth Rate (2019-2020)

7.3 Japan Fluorescein Angiography Sales and Growth Rate (2019-2020)

7.4 Korea Fluorescein Angiography Sales and Growth Rate (2019-2020)

7.5 India Fluorescein Angiography Sales and Growth Rate (2019-2020)

7.6 Southeast Asia Fluorescein Angiography Sales and Growth Rate (2019-2020)

7.7 Australia Fluorescein Angiography Sales and Growth Rate (2019-2020)

8 South America by Country

8.1 South America Fluorescein Angiography Sales, Revenue and Market Share by Country

8.1.1 South America Fluorescein Angiography Sales and Market Share by Country (2019-2020)

8.1.2 South America Fluorescein Angiography Revenue and Market Share by Country (2019-2020)

8.2 Brazil Fluorescein Angiography Sales and Growth Rate (2019-2020)

8.3 Argentina Fluorescein Angiography Sales and Growth Rate (2019-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Fluorescein Angiography Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Fluorescein Angiography Sales and Market Share by Country (2019-2020)

9.1.2 Middle East & Africa Fluorescein Angiography Revenue and Market Share by Country (2019-2020)

9.2 Saudi Arabia Fluorescein Angiography Sales and Growth Rate (2019-2020)

9.3 Turkey Fluorescein Angiography Sales and Growth Rate (2019-2020)

9.4 Egypt Fluorescein Angiography Sales and Growth Rate (2019-2020)

9.5 South Africa Fluorescein Angiography Sales and Growth Rate (2019-2020)

10 Global Fluorescein Angiography Market Segment by Product

10.1 Global Fluorescein Angiography Sales Market Share by Product (2019-2020)

10.2 Global Fluorescein Angiography Revenue Market Share by Product (2019-2020)

10.3 Global Fluorescein Angiography Price by Product (2019-2020)

11 Global Fluorescein Angiography Market Segment by Technology

11.1 Global Fluorescein Angiography Sales Market Share by Technology (2019-2020)

11.2 Global Fluorescein Angiography Revenue Market Share by Technology (2019-2020)

11.3 Global Fluorescein Angiography Price by Technology (2019-2020)

12 Global Fluorescein Angiography Market Segment by Application

12.1 Global Fluorescein Angiography Sales Market Share by Application (2019-2020)

12.2 Global Fluorescein Angiography Revenue Market Share by Application (2019-2020)

12.3 Global Fluorescein Angiography Price by Application (2019-2020)

13 Global Fluorescein Angiography Market Segment by End User

13.1 Global Fluorescein Angiography Sales Market Share by End User (2019-2020)

13.2 Global Fluorescein Angiography Revenue Market Share by End User (2019-2020)

13.3 Global Fluorescein Angiography Price by End User (2019-2020)

14 Market Forecast

14.1 Global Fluorescein Angiography Sales, Revenue and Growth Rate (2021-2027)

14.2 Fluorescein Angiography Market Forecast by Regions (2021-2027)

14.2.1 North America Fluorescein Angiography Market Forecast (2021-2027)

14.2.2 Europe Fluorescein Angiography Market Forecast (2021-2027)

14.2.3 Asia-Pacific Fluorescein Angiography Market Forecast (2021-2027)

14.2.4 South America Fluorescein Angiography Market Forecast (2021-2027)

14.2.5 Middle East & Africa Fluorescein Angiography Market Forecast (2021-2027)

14.3 Fluorescein Angiography Market Forecast by Product (2021-2027)

14.3.1 Global Fluorescein Angiography Sales Forecast by Product (2021-2027)

14.3.2 Global Fluorescein Angiography Market Share Forecast by Product (2021-2027)

14.4 Fluorescein Angiography Market Forecast by Technology (2021-2027)

14.4.1 Global Fluorescein Angiography Sales Forecast by Technology (2021-2027)

14.4.2 Global Fluorescein Angiography Market Share Forecast by Technology (2021-2027)

14.5 Fluorescein Angiography Market Forecast by Application (2021-2027)

14.5.1 Global Fluorescein Angiography Sales Forecast by Application (2021-2027)

14.5.2 Global Fluorescein Angiography Market Share Forecast by Application (2021-2027)

14.6 Fluorescein Angiography Market Forecast by End User (2021-2027)

14.6.1 Global Fluorescein Angiography Sales Forecast by End User (2021-2027)

14.6.2 Global Fluorescein Angiography Market Share Forecast by End User (2021-2027)

15 Sales Channel, Distributors, Traders and Dealers

15.1 Sales Channel

15.1.1 Direct Marketing

15.1.2 Indirect Marketing

15.2 Distributors, Traders and Dealers

16 Research Findings and Conclusion

17 Appendix

17.1 Methodology

17.2 Data Source

17.3 Disclaimer

17.4 About Us

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets